Notice: Function amp_is_available was called incorrectly. `amp_is_available()` (or `amp_is_request()`, formerly `is_amp_endpoint()`) was called too early and so it will not work properly. WordPress is currently doing the `init` hook. Calling this function before the `wp` action means it will not have access to `WP_Query` and the queried object to determine if it is an AMP response, thus neither the `amp_skip_post()` filter nor the AMP enabled toggle will be considered. It appears the plugin with slug `jetpack` is responsible; please contact the author. Please see Debugging in WordPress for more information. (This message was added in version 2.0.0.) in /home/grassnews/public_html/wp-includes/functions.php on line 5905
Medical Marijuana Market To Develop Strongly And Cross USD 30 Bn by the end of 2032 – GrassNews
Connect with us

Cannabis

Medical Marijuana Market To Develop Strongly And Cross USD 30 Bn by the end of 2032

Published

on

<!– Name:DistributionId Value:8785190 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:2790 –> <!– Name:CustomerId Value:1269133 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:8816b9c8-0419-40a8-a3bf-1dc5f260d5f8 –>

New York, March 09, 2023 (GLOBE NEWSWIRE) — The medical marijuana market globally was worth USD 13.8 billion in 2022, with the global market estimated to surge ahead at a CAGR of 8.3% to reach a valuation of USD 30 Bn by the end of 2032. Cannabis sativa is the plant from which medical marijuana, a well-known substance used by individuals to get high, is produced. A portion that can be smoked is the cannabis flower that is extracted from the female cannabis plant. The cannabis flower is full of natural chemicals and medicinal compounds. As a result, it is also recommended by medical professionals to treat the symptoms of some medical problems.

To get additional highlights on major revenue-generating segments, Request a Medical Marijuana market sample report at https://market.us/report/medical-marijuana-market/request-sample/

Key Takeaway:

  • By product type, 53.4% of the market share was accounted for by the oil and tincture segment in 2022.
  • By application, the chronic pain segment dominated the market by holding a market share of 26% in 2022.
  • By compound, the most lucrative market sector is likely to be CBD-dominant.
  • In terms of End-User, the pharmaceutical sector has dominated the market, and it is anticipated that it will continue to do so throughout the forecast period.
  • In 2022, North America held the largest revenue share (74%), dominating the market.

The market is expanding as people become more aware of the different therapeutic uses for goods including pain management, hunger augmentation, and intraocular pressure reduction. The two varieties of medical marijuana, Cannabis Sativa and Cannabis Indica, are native to the Western Hemisphere as well as Central and South Asia, respectively. 

Factors affecting the growth of Medical Marijuana industry?

  • Increasing marijuana use in the healthcare sector: A growing number of nations have made marijuana legal for medical purposes, and its use for recreational and industrial uses in the healthcare sector is also on the rise.
  • Surge in FDA approvals: To increase the sale of medical marijuana, leading market players are concentrating their efforts on obtaining FDA permission for the introduction of their new products in the market.
  • An increase in social clubs that support medical marijuana: The idea that medicinal marijuana should be accepted as a treatment for conditions like pain relief and other concerns originated among social gatherings, sometimes known as marijuana clubs.
  • Legalized the usage of medical marijuana: The use of medical marijuana is now legal in many countries, which is the primary route for its production, reducing imports and generating cash in the form of taxes.

To understand how Medical Marijuana market report can bring a difference to your business strategy, Inquire about a brochure at https://market.us/report/medical-marijuana-market/#inquiry

Top Trends in Global Medical Marijuana Market

Cannabinoid-based medications are used to treat a variety of conditions, including HIV/AIDS-related weight loss and appetite loss, vomiting and nausea brought on by chemotherapy, and a few uncommon forms of neurological diseases. Growing clinical trial initiatives for this marijuana will be a major factor in the market’s expansion. For instance, multiple studies supported by the National Center for Complementary and Integrative Health (NCCIH) are investigating the mechanisms of marijuana-related chemicals such terpenes and minor cannabinoids. These studies seek to bolster the evidence on marijuana’s active ingredients and determine whether they may have applications in the treatment of pain. Other medical cannabis research projects are being carried out by NCCIH, including studies on the effects of edible cannabis and its components on inflammation, chronic low-back pain, and investigations into the link between cannabis smoking and type 2 diabetes.

Market Growth

Demand for medical marijuana was significantly increased by the legalisation of marijuana use for illnesses, either to treat them or to lessen their symptoms, in accordance with various state regulations. Many conditions, including Alzheimer’s disease, severe nausea, and intense and continuous pain, can be treated with medical marijuana. Consequently, the market has been greatly aided by its wide range of medicinal uses.

Medicinal marijuana treats or manages asthma symptoms like coughing, breathing difficulties, and wheezing by acting as an instant bronchodilator, which relaxes the airways and facilitates breathing. Global demand for medical marijuana market is thus rising, which ultimately fuels the market’s expansion. This is owing to the healthcare sector’s expanding usage of medical marijuana.

Regional Analysis

One of the main causes of the rising demand for cannabis is the growing legalisation of marijuana in the United States. Also, 37 states and the District of Columbia in the US have approved cannabis for medical use. Cannabis usage for recreational purposes is allowed in ten additional states. The U.S. government recently allowed a new research marijuana grower, subject to the expansion of the capacity for researching the drug’s therapeutic benefits. New product introductions in North America are also anticipated to drive the cannabis market’s expansion.

Due to strong government initiatives and greater backing, the Asia-Pacific region is anticipated to experience the quickest CAGR in the next years. The cannabis market is undoubtedly being impacted by increased disposable incomes, expanding social acceptance and awareness of the product’s advantages, and escalating legalisation of cannabis. The market is expanding because of the rising demand for cannabis oil in nations where medical marijuana is permitted as well as the rising number of people who suffer from chronic diseases like Parkinson’s, Alzheimer’s, cancer, and neurological disorders.

Competitive Landscape

The competitive landscape of the medical marijuana market has also been examined in this report. Some of the major players include Tilray Brands Inc., Aurora Cannabis Inc., Canopy Growth Corporation, MedReleaf Corp., GW Pharmaceuticals, Cannabis Sativa Inc., Medical Marijuana Inc., VIVO Cannabis Inc., Cronos Group, Other Key Players.

Have Queries? Speak to an expert, or To Download/Request a Sample, Click here.

Medical Marijuana Market: Scope of the Report

Report Attribute Details
Market Value (2022) USD 13.8 Billion
Market Size (2032) USD 30.0 Billion
CAGR (from 2023 to 2032) 8.3%
North America Revenue Share 74%
Historic Period 2016 to 2022
Base Year 2022
Forecast Year 2023 to 2032

Market Drivers

Marijuana use for medical purposes is now permitted in several nations. Its cultivation is primarily done in this way, which lowers imports and generates revenue from taxes. Some of the major factors anticipated to influence demand for medical marijuana market in the next years include the rising number of states that have legalised it and the growing acceptance of cannabis for both medical and recreational purposes. Increasing research and development activities is one of the key elements driving demand growth.

One of the main factors influencing the prevalence of Cannabis for therapeutic use is the rising percentage of nations that approve its usage in various areas of the world. The need for medical marijuana fluctuates along with changes in governmental regulations.

The average age of cannabis users in U.S. states that have legalised the drug is above 50. With a higher incidence of chronic illness after age 50 and cannabis’ efficacy in treating such ailments, this demographic profile is predicted to enhance demand for cannabis in the area. The acceptance of cannabis as a medicine and product standardisation are likely to boost its appeal and demand. Also, the growing legalisation of marijuana for medical purposes is propelling market expansion. Critical variables driving up the use of cannabis include anxiety disorders, chronic illnesses, psychiatric disorders, acute diseases, acute pain diseases, and other clinical conditions.

Market Restraints

The FDA’s ban on marketing cannabis to cure any sickness or condition is one of the major obstacles facing the medical marijuana industry. However, the organisation does approve medications made from cannabis. Three synthetic cannabis-related medications, Marinol (dronabinol), Syndros (dronabinol), and Sesamet, as well as Epidiolex (cannabidiol) (nabilone) are available only with a prescription from an approved healthcare provider.

As cannabis has the greatest number of health advantages, it also carries some hazards and negative effects when used excessively, for an extended period of time, or in a toxic amount. Panic attacks and anxiety are a few of the side effects, while mental health problems and arrhythmia are long-term ones. Cannabis poisoning can result from consuming too much of the drug. 

Market Opportunities

When taking a capsule, the dosage must be correct in order to get the desired medical benefits. It is more dependable when produced by manufacturers who use advanced machinery and qualified inspectors with licences. Due to their therapeutic benefits, cannabis capsule demand has increased dramatically since medicinal cannabis became legal in the United States. As a result, investors are searching for properties to construct or buy that have the equipment, personnel, and permits required to produce cannabis capsules. Also, established manufacturers devote time and money to creating innovative techniques for creating high-quality capsules in manageable quantities.

Grow your profit margin with Market.us – Purchase Premium Medical Marijuana Market Report at https://market.us/purchase-report/?report_id=25269

Report Segmentation of the Medical Marijuana Market

Product Type Insight

The global medical marijuana market is divided into three categories based on the analysis of product types: flower, oil and tinctures. The oil and tincture section, which made up the majority of these segments and had a market share of 53.4% in 2022, is the one that leads the cannabis industry. It consequently controlled the medical marijuana business. Clinical research has demonstrated the anti-inflammatory properties of cannabis non-psychoactive components like CBD, which may provide new treatments for chronic pain.

In addition to treating cancer, sleep difficulties, anxiety disorders, and other conditions, it has many positive qualities. Additionally, it is anticipated that the sector would develop even faster as Cannabis becomes more and more legalised globally. Also, since smoking cannabis flowers may create respiratory issues in children, children who use cannabis derivatives for treatment are given oils and tinctures instead of smoking the flowers.

In the future years, it is expected that the flower category would grow more slowly. However, the debut of the new product is anticipated to accelerate this segment’s market growth.

Application Insight

The market is divided into Chronic Pain, Migraine, Cancer, Arthritis, Diabetes, AIDS, Parkinson’s, Epilepsy, Muscle Spasms, Depression, and Anxiety based on the application type. With a market share of 26% in 2022, the chronic pain segment led the other segments in terms of market size. Studies from a range of findings have shown that medical cannabis is safe for treating individuals with neuropathic and chronic pain. One of the key signs pointing to an increase in cannabis use for pain management over the coming years is the rise in clinical trials using the drug to treat neuropathic and chronic pain.

Under New York State’s new medical marijuana law, patients who are certified to use medical marijuana by a health care professional and have a patient ID card registered with the New York State Department of Health and Human Services are entitled to medical marijuana for pain management. It states that you are eligible to use marijuana for recreational purposes. However, ALS (Amyotrophic Lateral Sclerosis) is expected to be the fastest-growing segment. One of the driving factors behind the growth of this segment is the rising prevalence of ALS.

Compound Insight

The global medical marijuana market is divided into CBD-dominant, THC-dominant, and other compounds based on compound. The most profitable market sector is likely to be CBD-dominant. This is partly because CBD is mostly utilised for medical purposes and has low levels of toxicity and psychosis. THC, on the other hand, helps to decrease the negative effects of cancer and AIDS treatment. THC currently controls a large portion of the market. 

End-User Insight

The market is divided into pharmaceutical industries and research and development centres based on the end-user. The pharmaceutical segment was the market’s leading section in recent years, and it is anticipated that it will continue to be so during the forecast period. Because to the health advantages connected with cannabis use in specific medical diseases, pharmaceutical companies are investing more and using it more frequently, which is the primary reason for the rise of this market. The R&D facilities are anticipated to expand in the coming years as a result of increased funding for studies to find cures for various illnesses and learn about novel cannabis-related health advantages.

For more insights on the historical and Forecast Medical Marijuana Market Data from 2016 to 2032 – Download a sample report at https://market.us/report/medical-marijuana-market/request-sample/

Market Segmentation

By Product Type

  • Flower
  • Oil and Tinctures

By Application

  • Chronic Pain
  • Migraine
  • Cancer
  • Arthritis
  • Diabetes
  • AIDS
  • Parkinson’s
  • Epilepsy
  • Muscle spasms
  • Depression and Anxiety

By Compound

  • CBD-Dominant
  • THC-Dominant
  • Other Compounds

By End-User

  • Pharmaceutical Industries
  • Research & Development Centers
  • Other End-Users

By Geography

  • North America
    • The US
    • Canada
    • Mexico
  • Western Europe
    • Germany
    • France
    • The UK
    • Spain
    • Italy
    • Portugal
    • Ireland
    • Austria
    • Switzerland
    • Benelux
    • Nordic
    • Rest of Western Europe
  • Eastern Europe
    • Russia
    • Poland
    • The Czech Republic
    • Greece
    • Rest of Eastern Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia & New Zealand
    • Indonesia
    • Malaysia
    • Philippines
    • Singapore
    • Thailand
    • Vietnam
    • Rest of APAC
  • Latin America
    • Brazil
    • Colombia
    • Chile
    • Argentina
    • Costa Rica
    • Rest of Latin America
  • Middle East & Africa
    • Algeria
    • Egypt
    • Israel
    • Kuwait
    • Nigeria
    • Saudi Arabia
    • South Africa
    • Turkey
    • United Arab Emirates
    • Rest of MEA

Competitive Landscape 

The competitive landscape of the market has also been examined in this report. Some of the major players include,

  • Tilray Inc.
  • Aurora Cannabis
  • Canopy Growth Corporation
  • Aphria Inc.
  • Maricann Group, Inc.
  • Tikun Olam, Ltd.
  • GW Pharmaceuticals plc.
  • Cannabis Sativa Inc.
  • Medical Marijuana, Inc.
  • Emerald Health Therapeutics Inc.
  • Pfizer Inc.
  • Green Relief Inc.
  • GBSciences Inc.
  • Other Key Players

 Recent Development of the Medical Marijuana Market

  • Orange orbit and the grape, two new flavours for Canopy Growth’s flavoured cannabis-infused fizzy drinks, were unveiled in May 2022. The company’s product line was expanded as a result of this introduction.
  • A 15-flavor CBD Health Gummies Sampler was introduced by Martha Steard, Canopy Growth Corporation, and Marquee Brands in March 2022. These goods give customers access to CBD’s health advantages.

Browse More Related Reports:

  • Legal Marijuana Market size is expected to be worth around USD 121.11 Billion by 2032 from USD 12.9 Billion in 2022, growing at a CAGR of 25.1% during the forecast period from 2022 to 2032.
  • Delta-3-Carene Market size is expected to be worth around USD 87.33 Million by 2032 from USD 59 Million in 2022, growing at a CAGR of 4% during the forecast period 2023 to 2032.
  • Cannabidiol Market was valued at USD 5,250 million in 2022. They are expected to grow at a CAGR of 17.2% between 2023 and 2032.
  • Medicinal Cannabis Compounding Market ассоuntеd fоr UЅD 3,052.72 mіllіоn іn 2021 and САGR оf 21.3% оvеr thе fоrесаѕt реrіоd.

About Us:

Market.US (Powered by Prudour Pvt Ltd) specializes in in-depth market research and analysis and has been proving its mettle as a consulting and customized market research company, apart from being a much sought-after syndicated market research report-providing firm. Market.US provides customization to suit any specific or unique requirement and tailor-makes reports as per request. We go beyond boundaries to take analytics, analysis, study, and outlook to newer heights and broader horizons.

Follow Us on LinkedIn | Facebook | Twitter

Our Blog: 

Medical Marijuana Market


Cannabis

CBD Skin Care Market Size is projected to reach USD 6466.43 million by 2030, growing at a CAGR of 32.15%: Straits Research

Published

on

New York, United States, Sept. 20, 2023 (GLOBE NEWSWIRE) — Cannabidiol (CBD), derived from cannabis resin, is non-intoxicating. Cannabinoid (CBD) is most typically used with oils. CBD oil has anti-inflammatory, antioxidant, and skin-soothing properties. CBD oil is currently a popular ingredient in skin care and personal care products.

Since marijuana and cannabis-based cosmetics were legalized, CBD-infused skin care products have gained popularity. CBD-infused skin care products are popular because they relax. Anti-inflammatory and anti-oxidant properties make it a promising skin care ingredient. CBD-based skincare products can improve sleep and treat eczema, psoriasis, and acne. CBD-based skin care is popular among cosmetic brands. CBD-infused skin care is marketed as “natural cosmetics” CBD skin care products are expected to become popularity due to their versatility.

Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/cbd-skin-care-market/request-sample

Global CBD Skin Care MarketDRIVERS

  • Cannabis-Derived Skin Care Products Are Gaining Popularity

A surge in the working population around the world has increased spending power and awareness of the range of commodities on the market, boosting sales of quality products. These factors have led to growing global demand for natural and organic personal care items.

People are becoming increasingly familiar with the benefits of CBD skin care products, such as CBD oil in their daily coffee, using it to their skin to relieve pain, consuming it to relieve anxiety, and using it in their sex life.

  • Social-Media’s Impact on Skin Diseases

Because of pollution and UV radiation, which can cause skin burns, blackening, and cancer, consumers are turning to CBD-infused cosmetics and skincare products. Consumers’ increased acquaintance with the newest skin care products helps boost sales. Companies increasingly use celebrities to sell their products and spend a lot on advertising.

YouTube and Instagram are important influences on today’s society. These portals help people find CBD skin care products. Rising customer awareness of the benefits and availability of new products should benefit the global market in the futur

Global CBD Skin Care Market: KEY FUTURE OPPORTUNITIES

  • Technological Advances and Mergers Create New Opportunities

Recent scientific advances have resulted to innovative CBD extracts and combinations for skin care. CBD-infused goods from multinational firms are capturing new markets and establishing new cash streams. Avon plans to develop vegan skin care products with CBD oil in 2020. As the cannabis beauty industry grows, component approaches vary. These factors boost market growth.

A growing number of technological innovations are driven by a desire to lower production costs and to foster sustainable growth from 2022 to 2030.

Report Scope

Report Metric Details
Market Size by 2030 USD 6466.43 million
Market Size in 2021 USD 526.09 million
CAGR 32.15% (2022-2030)
Historical Data 2020-2021
Base Year 2022
Forecast Period 2023-2031
Forecast Units Value (USD million)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered By Technology, By Application, By Location
Geographies Covered North America, Europe, Asia-Pacific, LAME and Rest of the World
Key Companies Profiled/Vendors Kiehl’s LLC, Medical Marijuana, ENDOCA, Elixinol Global ltd, Lord Jones, Icanic Brands Company, Inc., LEEF Organics, The CBD Skincare Co, Kana Skincare, Apothecana, Josie Maran Cosmetics, FOLIUM BIOSCIENCES, CBD for life, Pacific Roots LLC,
Key Market Opportunities Technological Advances and Mergers Create New Opportunities
Key Market Drivers Cannabis-Derived Skin Care Products Are Gaining Popularity

Buy Now Full Report @ https://straitsresearch.com/buy-now/cbd-skin-care-market

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa make up the CBD Skin Care Market.

North America, which had over 45% of the market in 2021, is expected to grow quickest. Demand for CBD skin care products in North America is expected to continue high due to a large client base and the legalization of marijuana. Due to legalization in 33 states and DC, the US possesses the world’s largest cannabis market. Cannabis legalization and well-known beauty product makers should boost industry growth in the next years.

CBD-infused skin care products may fuel US customer demand. The FDA Regulation of Cannabidiol (CBD) Products prohibits marijuana but not hemp or cannabis. Manufacturing and selling CBD derivatives is lawful. CBD derivatives may be used as lotions, serums, and ointments.

Asia Pacific will grow rapidly in the future years. China, India, Japan, and Korea are expected to see substantial growth. J-beauty and K-beauty lead the worldwide skincare market, despite cannabis being illegal in Asia. This market is expected to grow rapidly in Asia.

China is one of the main manufacturers of cannabis made from hemp, and the World Bank and IMF expect it to monopolize the market throughout the predicted period. China allows the production and sale of CBD products with a maximum 0.3% THC content from cannabis Sativa fruit, seed oil, and leaf extract. This benefits its use in high-end skincare and luxury cosmetics.

Due to changing legislation, India’s CBD skin care market is growing. The Narcotic Drugs and Psychotropic Substances Act of 1985 says it’s unlawful to produce cannabis in the U.S., although states can allow its commercial or research cultivation.

Key Highlights

  • The Global CBD Skin Care Market size is predicted to reach at USD 6466.43 million by 2030, increasing at a CAGR of 32.15% from 2022 to 2030.
  • By Source,the Global CBD Skin Care Market is segmented into Hemp and Marijuana. CBD skin care products derived from hemp maintained the biggest market share.
  • By Type,the Global CBD Skin Care Market is segmented into Oils, Creams & Moisturizers, Masks & Serums, Cleansers, and Others. In 2021, the market was led by skin care oils containing CBD.
  • By Region,the Global CBD Skin Care Market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The market share is dominated by North America.

Major Players in Global CBD Skin Care Market

  1. Kiehl’s LLC
  2. Medical Marijuana
  3. ENDOCA
  4. Elixinol Global ltd
  5. Lord Jones
  6. Icanic Brands Company, Inc.
  7. LEEF Organics
  8. The CBD Skincare Co
  9. Kana Skincare
  10. Apothecana
  11. Josie Maran Cosmetics
  12. FOLIUM BIOSCIENCES
  13. CBD for life
  14. Pacific Roots LLC
  15. Ecogen labs

Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/cbd-skin-care-market/request-sample

Global CBD Skin Care Market: Segmentation

BY SOURCE

  • Hemp
  • Marijuana

BY TYPE

  • Oils
  • Creams & Moisturizers
  • Masks & Serums
  • Cleansers
  • Others

BY GEOGRAPHY

  • North America
  • Europe
  • Asia Pacific (APAC)
  • Latin America
  • Middle East and Africa (MEA)

TABLE OF CONTENT

  1. EXECUTIVE SUMMARY
  2. RESEARCH SCOPE & SEGMENTATION
    1. Research Objectives
    2. Market Definition
    3. Limitations & Assumptions
    4. Market Scope & Segmentation
    5. Currency & Pricing Considered
  3. MARKET OPPORTUNITY ASSESSMENT
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    4. Investment Landscape
    5. New Business Models / Revenue Streams
    6. TAM
  1. MARKET TRENDS
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Human Factors
    6. Technology Factors
  1. MARKET ASSESSMENT
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    3. Sales And Distribution Channel Analysis
    4. Average Pricing Analysis
    5. Patent Analysis
    6. M & A Agreements & Collabration Analysis
    7. Export Import Analysis
  1. ESG TRENDS
  2. GLOBAL CBD SKIN CARE MARKET SIZE ANALYSIS
    1. Global CBD Skin Care Market Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      1. Hemp
        1. By Value
      1. Marijuana
        1. By Value
    1. By Type
      1. Introduction
        1. Type By Value
      1. Oils
        1. By Value
      1. Creams & Moisturizers
        1. By Value
      1. Masks & Serums
        1. By Value
      1. Cleansers
        1. By Value
      1. Others
        1. By Value
  1. NORTH AMERICA MARKET ANALYSIS
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      1. Hemp
        1. By Value
      1. Marijuana
        1. By Value
    1. By Type
      1. Introduction
        1. Type By Value
      1. Oils
        1. By Value
      1. Creams & Moisturizers
        1. By Value
      1. Masks & Serums
        1. By Value
      1. Cleansers
        1. By Value
      1. Others
        1. By Value
    1. U.S.
      1. By Source
        1. Introduction
          1. Source By Value
        2. Hemp
          1. By Value
        3. Marijuana
          1. By Value
      1. By Type
        1. Introduction
          1. Type By Value
        2. Oils
          1. By Value
        3. Creams & Moisturizers
          1. By Value
        4. Masks & Serums
          1. By Value
        5. Cleansers
          1. By Value
        6. Others
          1. By Value
    1. Canada
  1. EUROPE MARKET ANALYSIS
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      1. Hemp
        1. By Value
      1. Marijuana
        1. By Value
    1. By Type
      1. Introduction
        1. Type By Value
      1. Oils
        1. By Value
      1. Creams & Moisturizers
        1. By Value
      1. Masks & Serums
        1. By Value
      1. Cleansers
        1. By Value
      1. Others
        1. By Value
    1. U.K.
      1. By Source
        1. Introduction
          1. Source By Value
        2. Hemp
          1. By Value
        3. Marijuana
          1. By Value
      1. By Type
        1. Introduction
          1. Type By Value
        2. Oils
          1. By Value
        3. Creams & Moisturizers
          1. By Value
        4. Masks & Serums
          1. By Value
        5. Cleansers
          1. By Value
        6. Others
          1. By Value
    1. Germany
    2. France
    3. Spain
    4. Italy
    5. Russia
    6. Nordic
    7. Benelux
    8. Rest Of Europe
  1. APAC MARKET ANALYSIS
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      1. Hemp
        1. By Value
      1. Marijuana
        1. By Value
    1. By Type
      1. Introduction
        1. Type By Value
      1. Oils
        1. By Value
      1. Creams & Moisturizers
        1. By Value
      1. Masks & Serums
        1. By Value
      1. Cleansers
        1. By Value
      1. Others
        1. By Value
    1. China
      1. By Source
        1. Introduction
          1. Source By Value
        2. Hemp
          1. By Value
        3. Marijuana
          1. By Value
      1. By Type
        1. Introduction
          1. Type By Value
        2. Oils
          1. By Value
        3. Creams & Moisturizers
          1. By Value
        4. Masks & Serums
          1. By Value
        5. Cleansers
          1. By Value
        6. Others
          1. By Value
    1. Korea
    2. Japan
    3. India
    4. Australia
    5. Taiwan
    6. South East Asia
    7. Rest Of Asia-Pacific
  1. MIDDLE EAST AND AFRICA MARKET ANALYSIS
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      1. Hemp
        1. By Value
      1. Marijuana
        1. By Value
    1. By Type
      1. Introduction
        1. Type By Value
      1. Oils
        1. By Value
      1. Creams & Moisturizers
        1. By Value
      1. Masks & Serums
        1. By Value
      1. Cleansers
        1. By Value
      1. Others
        1. By Value
    1. UAE
      1. By Source
        1. Introduction
          1. Source By Value
        2. Hemp
          1. By Value
        3. Marijuana
          1. By Value
      1. By Type
        1. Introduction
          1. Type By Value
        2. Oils
          1. By Value
        3. Creams & Moisturizers
          1. By Value
        4. Masks & Serums
          1. By Value
        5. Cleansers
          1. By Value
        6. Others
          1. By Value
    1. Turkey
    2. Saudi Arabia
    3. South Africa
    4. Egypt
    5. Nigeria
    6. Rest Of MEA
  1. LATAM MARKET ANALYSIS
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      1. Hemp
        1. By Value
      1. Marijuana
        1. By Value
    1. By Type
      1. Introduction
        1. Type By Value
      1. Oils
        1. By Value
      1. Creams & Moisturizers
        1. By Value
      1. Masks & Serums
        1. By Value
      1. Cleansers
        1. By Value
      1. Others
        1. By Value
    1. Brazil
      1. By Source
        1. Introduction
          1. Source By Value
        2. Hemp
          1. By Value
        3. Marijuana
          1. By Value
      1. By Type
        1. Introduction
          1. Type By Value
        2. Oils
          1. By Value
        3. Creams & Moisturizers
          1. By Value
        4. Masks & Serums
          1. By Value
        5. Cleansers
          1. By Value
        6. Others
          1. By Value
    1. Mexico
    2. Argentina
    3. Chile
    4. Colombia
    5. Rest Of LATAM
  1. COMPETITIVE ASSESSMENT
    1. CBD Skin Care Market Share By Manufacturers
    2. CBD Skin Care Market Ranking By Revenue For Manufacturers
    3. Competitive Dashboard
    4. Product Mapping
  1. MARKET PLAYERS ASSESSMENT
    1. Kiehl’s LLC
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. Gross Margin
      6. Swot Analysis
      7. Recent Developmments
    1. Medical Marijuana
    2. ENDOCA
    3. Elixinol Global Ltd
    4. Lord Jones
    5. Icanic Brands Company, Inc.
    6. LEEF Organics
    7. The CBD Skincare Co
    8. Kana Skincare
    9. Apothecana
    10. Josie Maran Cosmetics
    11. FOLIUM BIOSCIENCES
    12. CBD For Life
    13. Pacific Roots LLC
    14. Ecogen Labs
  1. RESEARCH METHODOLOGY
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data From Secondary Sources
      1. Primary Data
        1. Key Data From Primary Sources
        2. Breakdown Of Primaries
      1. Secondary And Primary Research
        1. Key Industry Insights
    1. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    1. Research Assumptions
      1. Assumptions
    1. Limitations
    2. Risk Assessment
  1. APPENDIX
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  1. DISCLAIMER

Table of Content and Figure @ https://straitsresearch.com/report/cbd-skin-care-market/toc

News Media

Global CBD Skin Care Market Extends at a Healthy CAGR of 32.15%

Consumer Preference Drives the CBD Skin Care Products Market despite the Stringent Regulatory Landscape in Many Countries

Have a Look at the Related Research Report

Skincare Products Market: Information by Product Type (Facial Care, Lip Care, and Body Care), Category (Premium Skincare Products and Mass Skincare Products), and Region- Forecast till 2030

Skincare Body Products Market: Information by Gender (Male and Female), Product (Face Creams and Moisturizers), and Region — Forecast till 2030

Organic Skin Care Market: Information by Product (Face Cleanser, Face Serum), Distribution Channel (Online, Supermarket/Hypermarket), and Region — Forecast till 2030

Facial Skincare Products Market: Information by Product Type (Facial Cleanser, Toner, Facial Serum, Eye Creams), Distribution Channel (Specialty Stores), and Region — Forecast till 2030

About Straits Research Pvt. Ltd.

Straits Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.

Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.

For more information on your target market, please contact us below:

Phone: +1 646 905 0080 (the U.S.)

+91 8087085354 (APAC)

+44 203 695 0070 (the U.K.)

Email: sales@straitsresearch.com

Follow Us: LinkedIn | Facebook | Instagram | Twitter

Continue Reading

Cannabis

Legal Cannabis Commercialization Bolsters Vacuum Oven Demand; Essential Role in Processing Extracts and Enhancing Safety Recognized

Published

on

Dublin, Sept. 20, 2023 (GLOBE NEWSWIRE) — The “Vacuum Ovens Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering.

The global vacuum ovens market exhibited strong growth in 2022, reaching a total valuation of US$ 234.3 million. According to this report the market is poised for continued expansion, with expectations to reach US$ 343.2 million by 2028. This growth reflects a robust compound annual growth rate (CAGR) of 6.38% during the forecast period from 2023 to 2028.

Vacuum ovens, highly versatile equipment with applications in laboratory research, engineering, and industry, play a pivotal role in the heat treatment process. These ovens conduct heat treatment within an airtight vessel, allowing the creation of a vacuum within the chamber. This capability enables precise control over the heat treatment process and offers several advantages, including:

  1. Prevention of surface reactions like oxidation or decarburization.
  2. Removal of surface contaminants such as oxide films and residual traces of lubricants.
  3. Introduction of substances to the surface layers of the work.
  4. Removal of dissolved contaminating materials from metals through degassing.

The vacuum oven market’s growth is closely tied to the legalization of cannabis in many parts of the world and the subsequent commercialization of related products. Vacuum ovens play a crucial role for legal cannabis growers in processing cannabis extract BHOs (Butane Hash oil).

These ovens enable the production of purified oil extracts while reducing the risk of fires during the extraction process. Furthermore, vacuum ovens are used in the medical industry to eliminate potentially toxic chemicals from medical devices, including artificial heart valves, pacemakers, and joint implants. These ovens also find application in testing how devices respond to the high vacuum environment of space, making them valuable equipment for the aerospace industry.

Key Market Segmentation:

The global vacuum ovens market report by [Publisher Name] analyzes key trends within each sub-segment and provides forecasts at the global and regional levels for the period from 2023 to 2028. The market is segmented based on product type and application.

Product Type:

  • < 200
  • 200-300
  • > 300

Application:

  • Home Appliances
  • Commercial Appliances

Regional Insights:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Competitive Landscape:

The report offers a comprehensive analysis of the competitive landscape, featuring key players such as Cole-Parmer, Memmert GmbH+Co.KG, MTI Corporation, Sheldon Manufacturing Inc, Thermo Fisher Scientific, Accumax India, BINDER GmbH, Cascade TEK, ESPEC, Grieve, JEIO, SalvisLab Renggli, Shanghai Hasuc Instrument, Ted Pella, and Yamato Scientific.

This report provides in-depth insights into the global vacuum ovens market, covering macro overviews, micro details of industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, and more. It is a crucial resource for entrepreneurs, investors, researchers, consultants, business strategists, and anyone involved or planning to enter the vacuum ovens industry.

Key Questions Answered in This Report:

  • How has the global vacuum ovens market performed and what are the growth prospects in the coming years?
  • Which regions are the primary markets in the global vacuum ovens industry?
  • What impact has COVID-19 had on the global vacuum ovens industry?
  • How is the global vacuum ovens market segmented based on product type?
  • What are the applications driving the global vacuum ovens market?
  • What are the price trends for vacuum ovens?
  • What is the value chain structure of the global vacuum ovens market?
  • What are the key factors driving growth and challenges in the global vacuum ovens market?
  • Who are the major players in the global vacuum ovens market, and what is the competitive landscape like?
  • How are vacuum ovens manufactured?

Key Attributes:

Report Attribute Details
No. of Pages 139
Forecast Period 2022 – 2028
Estimated Market Value (USD) in 2022 $254.3 Million
Forecasted Market Value (USD) by 2028 $343.2 Million
Compound Annual Growth Rate 5.1%
Regions Covered Global

For more information about this report visit https://www.researchandmarkets.com/r/n83xum

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment


Continue Reading

Cannabis

Endexx Announces Amended Consolidated 10-Q/A: Quarterly Report for The Quarter Ending March 31, 2023, Increasing Year-Over-Year 1013%

Published

on

Endexx Year Over Year Six Month Revenues Grew 528%

CAVE CREEK, AZ, Sept. 19, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Endexx® Corporation (OTCQB: EDXC), a provider of innovative plant-based wellness and nutritional products, announced today the filing of its amended, consolidated, audited 10-Q/A Quarterly report for the quarter ending March 31, 2023.

Endexx Milestones and Highlights for the quarter ending March 31, 2023

● Year-over-year quarterly revenues increased 1013% from $254,686 to $2,833,378.

● For the six months ended March 31, 2023, Endexx recorded a 528% increase in revenue, from $529,277 to $3,326,087 Year-Over-Year for the same period.

● Six-month losses year-over-year improved, March 31, 2023 were $2,584,678 compared to $4,426,299 in the same period of fiscal 2022.

“Consolidating the audited financials and integrating Hyla’s operations into Endexx, we’ve catapulted into an era marked by unprecedented growth, painting Fiscal 2023 as a canvas of resurgence and robust expansion amidst a two-year stagnation in the cannabis and hemp industry,” said Todd Davis. “This synergy has not just revitalized our foothold in the domestic market but has also catapulted us onto the global stage, significantly multiplying our retail presence into 11 countries, particularly during the initial half of Fiscal 2023.”

www.endexx.com & www.cbdunlimited.com

www.tryhyla.com

About Endexx Corporation

Endexx Corporation develops and distributes all natural, plant-derived wellness products and topical skincare products.  Its products vary from balms, creams, lotions, butters, masks, scrubs, and oils, all with the shared purpose of healthy skin and grooming wellness.  The science behind these products involves a decade of clinical research in the field and lab work to provide functional formulation with ingredients for optimal absorption and support of skin health. www.endexx.com

Hyla currently markets its proprietary non-nicotine, guarana and L-Dopa-based vape products in a wide variety of flavors. The Hyla device is the first non-nicotine vape product to be produced in this manner in the United States and provides an unprecedented 4,500 puffs per device. Hyla is currently being distributed in 10 countries and has signed distribution agreements with an additional nine countries. www.tryhyla.com

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995

We caution that any forward-looking statements (as such term is defined in the U.S. Private Securities Litigation Reform Act of 1995) contained in this press release or made by us, our management, or our spokespeople involve risks and uncertainties and are subject to change based on various factors, many of which are beyond our control. Accordingly, our future performance and financial results may differ materially from those expressed or implied in any such forward-looking statements. Forward-looking statements include, without limitation, statements regarding our future operating results, the implementation and impact of our strategic plans, and our ability to meet environmental, social, and governance goals. Words such as “estimate,” “commit,” “target,” “goal,” “project,” “plan,” “believe,” “seek,” “strive,” “expect,” “anticipate,” “intend,” “potential” and any similar expressions may identify forward-looking statements. Risks associated with the following factors, among others, could affect our financial performance and cause actual results to differ materially from those expressed or implied in any forward-looking statements.

Except as may be required by law, we assume no obligation and do not intend to make publicly available any update or other revisions to any of the forward-looking statements contained in this press release to reflect circumstances existing after the date of this press release or to reflect the occurrence of future events, even if experience or future events make it clear that any expected results expressed or implied by those forward-looking statements will not be realized. More information on potential factors that could affect our results is included “Risk Factors” in our amended Annual Report on Form 10-K/A filed with the Securities and Exchange Commission on June 9, 2023.

No Offer or Solicitation. This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.  No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and, where applicable, the requirements under the securities laws of any other applicable jurisdiction.

For further information, please contact:
Endexx Corporation
IR@Endexx.com
480-595-6900

Continue Reading
Advertisement

Latest news

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: sales@hipther.agency

Editorial / PR Submissions

Copyright © 2007 - 2023 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania